Cointime

Pieris AG

company

About

Pieris Pharmaceuticals is a clinical-stage biotechnology company that develops drugs to fight cancer, severe asthma, anemia, and so on.

  • 101 - 250

Highlights

Total Funding Amount
€12M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series A
Last Funding Money Raised
€12M
Industries
Biotechnology,Health Care,Medical,Pharmaceutical
Founded date
Jan 1, 2001
Number Of Employee
101 - 250
Operating Status
Active

Pieris Pharmaceuticals is a clinical-stage biotechnology company that develops drugs to fight cancer, severe asthma, anemia, and other medical conditions with unmet medical needs. The company applies its proprietary Anticalin® technology to the drug development processes.

Pieris Pharmaceuticals was founded in 2001 and is based in Freising, Bayern.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€12M
Pieris AG has raised a total of €12M in funding over 2 rounds. Their latest funding was raised on Oct 31, 2002 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 31, 2002 Series A €12M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Pieris AG is funded by 1 investors. BioM Venture Capital are the most recent investors.
Investor Name Lead Investor Funding Round
BioM Venture Capital — Series A
Cointime
เนื้อหา
บริษัท